血液恶性瘤中的JAK-STAT通路:成就,挑战和未来的前景
Bing Pan1, Kaixin Shi1, Yuxiao Li1
1Department of Hematology, The Second Hospital of Dalian Medical University, Dalian, China.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
|January 7, 2026
概括
该JAK-STAT通路对细胞功能至关重要,并与血液癌症有关. 本综述总结了JAK-STAT信号,其在血液恶性瘤中的作用,以及新兴的向疗法.
科学领域:
- 细胞生物学 细胞生物学
- 病理学 病理学 病理学
- 分子生物学分子生物学
背景情况:
- 简氏酶信号转换器和转录激活器 (JAK-STAT) 信号通路是一个关键的细胞通信系统.
- 这条通路调节了包括增殖,分化,生存和亡在内的基本细胞过程.
- 对JAK-STAT信号的调节失调与免疫系统疾病和癌症的发展有关,特别是血液恶性瘤.
研究的目的:
- 提供JAK-STAT信号通道的全面概述.
- 阐明JAK-STAT信号在血液恶性瘤的发病过程中的作用.
- 总结针对血液恶性瘤的JAK-STAT通路的当前和新兴治疗策略.
主要方法:
- 对JAK-STAT信号通路的文献综述.
- 分析JAK-STAT组件与血液恶性瘤之间的关系.
- 收集关于FDA批准和临床前药物针对该途径的信息.
主要成果:
- 详细介绍了JAK-STAT通路的组成,激活和调节.
- 建立了JAK-STAT信号与血液恶性瘤之间的复杂联系.
- 介绍了当前的治疗场景,包括已批准和正在研究的药物.
结论:
- 了解JAK-STAT通路调节对于开发血液恶性瘤的有效治疗至关重要.
- 准JAK-STAT通路为血液癌症提供了有前途的治疗途径.
- 持续的研究对于应对挑战和探索JAK-STAT向治疗的未来方向至关重要.
相关概念视频
The JAK-STAT Signaling Pathway
11.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
11.9K
Overview of Hematopoiesis
8.3K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
8.3K
Regulation of Hematopoietic Stem Cells
3.9K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.9K
Role of Hematopoietic Growth Factors
3.1K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
3.1K
Hematopoiesis
8.6K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
8.6K
Multipotency of Hematopoietic Stem Cells
3.8K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.8K


